PharmaJen

Hyderabad, India Founded: 2021 • Age: 5 yrs
Offers drug discovery services like DMPK, chemistry, and toxicology studies.

About PharmaJen

PharmaJen is a Healthcare company based in Hyderabad (India) founded in 2021. It offers drug discovery services like DMPK, chemistry, and toxicology studies. It operates on a B2B model. Its Indian entity Pharmajen Laboratories Private Limited reported revenue of β‚Ή41.1 Lakh. PharmaJen offers products and services including DMPK Services, Chemistry Services, Bioanalysis Services, and Preclinical Toxicology. Its focus areas include Life Sciences, Biotechnology, Drug Discovery and DMPK Services.

Company details

PharmaJen Laboratories Private Limited specializes in drug discovery, providing services such as DMPK, chemistry, bioanalysis, and preclinical toxicology. They conduct in vitro and in vivo studies, including ADME and pharmacokinetics, to support pharmaceutical research. Based in Hyderabad, India, they offer tailored solutions to biotech and pharma organizations, ensuring compliance with regulatory guidelines for efficient drug development.

  • Headquarters Hyderabad, India
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website pharmajen.com
  • Social LinkedIn
  • Legal Name Pharmajen Laboratories Private Limited
  • Date of Incorporation 05 Jul, 2021
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics
  • Annual Revenue
    ₹41.1 Lakh

    FY 2025 · -57% YoY

  • Net Loss
    -₹54.1 Lakh

    FY 2025 · -132% margin

  • EBITDA
    -₹22.5 Lakh

    FY 2025 · -55% margin

Products & Services of PharmaJen

PharmaJen offers a comprehensive portfolio of products and services, including DMPK Services, Chemistry Services, Bioanalysis Services, and Preclinical Toxicology.

DMPK Services
Drug Metabolism

Provides ADME and pharmacokinetics for drug discovery acceleration

Chemistry Services
Chemical Synthesis

Offers custom synthesis and process optimization for drug programs

Bioanalysis Services
Analytical Testing

Delivers metabolite quantification using UPLC-MS/MS technology

Preclinical Toxicology
Safety Assessment

Conducts toxicity tests for early-stage drug candidate evaluation

Board of directors of Pharmajen Laboratories Private Limited (PharmaJen)

Pharmajen Laboratories Private Limited is the primary company behind PharmaJen. The board of Pharmajen Laboratories Private Limited currently have 2 directors; the longest-serving is Tanaje Venkata Radha Krishna Mullapudi, appointed in 2021. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Tanaje Venkata Radha Krishna Mullapudi
DIN 07694588
Director05 Jul 20215 yrs 4 moPharmajen Laboratories Private Limited
Venugopal Reddy Gadiko
DIN 09731352
Director07 Sep 20224 yrs 2 moPharmajen Laboratories Private Limited

Financials of PharmaJen

Figures of Pharmajen Laboratories Private Limited, the primary company behind PharmaJen, for FY 2025. Revenue was ₹41.1 Lakh (-57% year on year). Net loss was -₹54.1 Lakh (-132% margin). EBITDA was -₹22.5 Lakh (-55% margin). Revenue has grown at a compounded annual rate of +701% over three years.

  • ₹41.1 LakhRevenue · FY 2025 · -57% YoY
  • -₹54.1 LakhNet loss · -132% margin
  • -₹22.5 LakhEBITDA · -55% margin
  • ₹52 LakhPaid-up capital
  • 6Employees (provident fund records)
  • +701%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Pharmajen Laboratories Private Limited are on its company page.

Premium access

Detailed financial statements for PharmaJen

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about PharmaJen

PharmaJen was founded in 2021.

PharmaJen is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

The primary company behind PharmaJen, Pharmajen Laboratories Private Limited, reported revenue of β‚Ή41.1 Lakh for FY 2025, down 57% year on year.

PharmaJen Laboratories Private Limited specializes in drug discovery, providing services such as DMPK, chemistry, bioanalysis, and preclinical toxicology. They conduct in vitro and in vivo studies, including ADME and pharmacokinetics, to support pharmaceutical research. Based in Hyderabad, India, they offer tailored solutions to biotech and pharma organizations, ensuring compliance with regulatory guidelines for efficient drug development.

PharmaJen offers DMPK Services, Chemistry Services, Bioanalysis Services, and Preclinical Toxicology.

PharmaJen operates through Pharmajen Laboratories Private Limited.

The legal entities of PharmaJen currently have 2 directors, including Venugopal Reddy Gadiko, Tanaje Venkata Radha Krishna Mullapudi.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available